FR2446819B1 - Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant - Google Patents

Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant

Info

Publication number
FR2446819B1
FR2446819B1 FR8001220A FR8001220A FR2446819B1 FR 2446819 B1 FR2446819 B1 FR 2446819B1 FR 8001220 A FR8001220 A FR 8001220A FR 8001220 A FR8001220 A FR 8001220A FR 2446819 B1 FR2446819 B1 FR 2446819B1
Authority
FR
France
Prior art keywords
dihydro
pharmaceutical composition
composition containing
alkyl derivatives
oxonicotinic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8001220A
Other languages
English (en)
Other versions
FR2446819A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2446819A1 publication Critical patent/FR2446819A1/fr
Application granted granted Critical
Publication of FR2446819B1 publication Critical patent/FR2446819B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/69—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/185—Saturated compounds containing keto groups bound to acyclic carbon atoms containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/24—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
FR8001220A 1979-01-22 1980-01-21 Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant Expired FR2446819B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,454 US4220648A (en) 1979-01-22 1979-01-22 Antidiabetic 1,2-dihydro-2-oxo-6-neopentyl-nicotinic acids

Publications (2)

Publication Number Publication Date
FR2446819A1 FR2446819A1 (fr) 1980-08-14
FR2446819B1 true FR2446819B1 (fr) 1986-02-28

Family

ID=21715959

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8001220A Expired FR2446819B1 (fr) 1979-01-22 1980-01-21 Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant

Country Status (8)

Country Link
US (1) US4220648A (fr)
JP (1) JPS55100363A (fr)
BE (1) BE881278A (fr)
DE (1) DE2952652A1 (fr)
FR (1) FR2446819B1 (fr)
GB (1) GB2040287B (fr)
IT (1) IT8047619A0 (fr)
NL (1) NL7909349A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314063A (en) * 1979-07-13 1982-02-02 Hoffmann-La Roche Inc. 1-Ethyl-1,4,5,6-tetrahydro-6-(2-naphthyl)-4-oxo-nicotinic acid and lower alkyl esters thereof
US4288440A (en) * 1980-08-29 1981-09-08 The Upjohn Company Pyridinones
US4645766A (en) * 1981-10-19 1987-02-24 The Upjohn Company 1,2-dihydro-2-oxo-3-hydroxymethyl pyridines, compositions and use
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US4849522A (en) * 1983-11-03 1989-07-18 Merrell Dow Pharmaceuticals Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
ZA848428B (en) * 1983-11-03 1985-06-26 Merrell Pharma Inc Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
JP4065018B2 (ja) * 2005-05-17 2008-03-19 森永乳業株式会社 膵臓機能改善のための医薬又は飲食品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873523A (en) * 1972-12-15 1975-03-25 Parke Davis & Co Derivatives of ampicillin
US4038065A (en) * 1974-10-11 1977-07-26 Rohm And Haas Company 1-alkylpyrid-2-one
DE2637477A1 (de) * 1976-08-20 1978-02-23 Hoechst Ag Dihydro-oxo-nicotinsaeuren und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE2952652A1 (de) 1980-07-24
JPS55100363A (en) 1980-07-31
GB2040287B (en) 1982-12-08
US4220648A (en) 1980-09-02
FR2446819A1 (fr) 1980-08-14
NL7909349A (nl) 1980-07-24
GB2040287A (en) 1980-08-28
BE881278A (fr) 1980-07-22
IT8047619A0 (it) 1980-01-16

Similar Documents

Publication Publication Date Title
MC1300A1 (fr) Proteines purifiees,procede de preparation et compositions pharmaceutiques les contenant
BE873500A (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
FR2602974B1 (fr) Composition pharmaceutique contenant de la nicotine ou ses derives
FR2569402B1 (fr) Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
FR2466248B1 (fr) Derives d'agents anti-inflammatoires non steroides, procede de preparation et compositions pharmaceutiques les contenant
BE876732A (fr) Nouveaux aminothiazoles et composition pharmaceutique les contenant
PT78340B (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
LU78330A1 (fr) Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant
FR2411839B1 (fr) Derives de l'acide cephalosporanique, procedes pour leur preparation et composition pharmaceutique les contenant
PT79927B (fr) Procede de preparation de nouveaux derives du 2-cyano-benzimidazole et de compositions pesticides les contenant
BE880065A (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
FR2446819B1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
PT78275A (fr) Procede de preparation de nouveaux acides flavone-carboxyliques-4' et de compositions pharmaceutiques les contenant
FR2490491B1 (fr) Composition pharmaceutique analgesique contenant comme ingredient actif l'acide 3-amino-2-hydroxy-4 phenylbutanoique et ses derives et application
FR2343730A1 (fr) Derives d'acide amidinoformique ou d'acide amidinosulfinique, leur preparation et compositions pharmaceutiques les contenant
PT82364A (fr) Procede de preparation de derives du nitrofuranne et de compositions pharmaceutiques les contenant
BE878020A (fr) Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant
PT80111B (fr) Procede de preparation de nouveaux arylthio-pyridinyl-alcanole et de compositions fongicides les contenant
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
FR2329281A1 (fr) Nouveaux 6,8-dioxamorphinanes n-substitues et composition pharmaceutique les contenant
BE884530A (fr) Nouveaux hexahydro-trans-pyrido-indoles et composition pharmaceutique les contenant
BE883859A (fr) Nouveaux pyridylaminotriazoles et composition pharmaceutique les contenant
FR2316928A1 (fr) Acide 2,4,6-triiodo-5-methoxyacetamido-n-methylisophtalamique et ses derives et composition pharmaceutique les contenant
PT82853A (fr) Procede de preparation de nouveaux benzamides et des compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse